Rheumatology 2000; 39: 346-349
© 2000 British Society for Rheumatology
Editorials |
Secondary prevention of hip fracture
Department of Rheumatology, Epsom & St Helier NHS Trust, Carshalton, Surrey SM5 1AA and
1 Osteoporosis Unit, Department of Rheumatology, St George's Hospital, London SW17 0QT, UK.
Many risk factors for diseases are asymptomatic until the pathology is severe enough to result in clinical expression of disease. For example, hypercholesterolaemia with coronary artery disease can be asymptomatic until a myocardial infarction occurs. Likewise hypertension may pre-date stroke. Following treatment of acute clinical events such as myocardial infarction and stroke, protocols are now established for prevention of further organ damage by modification of underlying risk factors, i.e. secondary prevention [1, 2]. Thus, all patients who have had an acute myocardial infarction should have their serum cholesterol measured and, if high, treated with drugs like statins to reduce the risk of future myocardial infarction [1].
Osteoporosis is analogous to these vascular diseases, having a prolonged asymptomatic phase of bone loss and gradual increase in fall risk with age. Although protocols for secondary prevention in myocardial infarction and stroke are being widely followed, appropriate management
Notes
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Patel, A. L. Dolan, V. Hajela, N. Cheung, and R. Keen Does giving osteoporosis patient information to women who have had a fracture improve access to health care? Rheumatology, March 1, 2004; 43(3): 387 - 389. [Full Text] [PDF] |
||||
![]() |
M. J. Gardner, K. R. Flik, P. Mooar, and J. M. Lane Improvement in the Undertreatment of Osteoporosis Following Hip Fracture J. Bone Joint Surg. Am., August 12, 2002; 84(8): 1342 - 1348. [Abstract] [Full Text] [PDF] |
||||

